Dasatinib-Responsive Mast Cell Neoplasms As Initial Presentation of Chronic Myelogenous Leukemia in Blast Phase-Reference-Cited by-同舟云学术

Dasatinib-Responsive Mast Cell Neoplasms As Initial Presentation of Chronic Myelogenous Leukemia in Blast Phase

Published:2011-06-10 Issue:17 Volume:29 Page:e514-e516
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Vigil Carlos E.¹,Wang Sa A.¹,Cortes Jorge E.¹,Bueso-Ramos Carlos¹,Verstovsek Srdan¹,Shinder Roman¹,Chen Su S.¹,Katz Ruth L.¹,Khanna Abha¹,Esmaeli Bita¹,Manning John T.¹,You M. James¹,Miranda Roberto N.¹

Affiliation:

1. The University of Texas MD Anderson Cancer Center, Houston, TX

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.34.1610

Reference20 articles.

1. Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells

2. TaqMan RT-PCR assay coupled with capillary electrophoresis for quantification and identification of bcr-abl transcript type

3. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation

4. JAK2 V617F mutation is uncommon in patients with the 3q21q26 syndrome

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Rare Case of Systemic Mastocytosis with Associated Hematologic Neoplasm (SM-AHN) Involving Chronic Myeloid Leukemia: A Case Report and Literature Review;American Journal of Case Reports;2020-04-06

2. A case report and case review: Chronic myeloid leukemia (CML) blast phase with myelomastocytic differentiation;Leukemia Research Reports;2020

3. Management of Hematologic Disease in Mastocytosis;Mastocytosis;2019-12-02

4. Myelomastocytic Blast Cell Crisis in Resistant Tyrosine Kinase Inhibitor Chronic Myelogenous Leukemia: Case Report and Review of Literature;Cureus;2019-05-21

5. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: Clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components;American Journal of Hematology;2013-02-25